跳至主要内容
临床试验/NCT05602103
NCT05602103尚未招募不适用

Identification of Anticancer Drugs Associated With Cancer Therapy-related Cardiac Dysfunction Reporting in Pediatrics - Analysis of the WHO Pharmacovigilance Database

University Hospital, Caen0 个研究点目标入组 10,000 人开始时间: 2024年11月5日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
尚未招募
入组人数
10,000
主要终点
cancer therapy-related cardiac dysfunction associated with anticancer drugs

研究概览

简要总结

Little is known about cancer therapy-related cardiac dysfunction occuring in children treated by anticancer drugs for malignancies. Here the investigators use VigiBase (http://www.vigiaccess.org/), the World Health Organization (WHO) database of individual safety case reports, to identify and describe cases of cancer therapy-related cardiac dysfunction associated with anticancer drugs.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
0 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • cases reported in the World Health Organization (WHO) database of individual safety case reports (vigibase)
  • related to children
  • and reported, or not, cancer therapy-related cardiac dysfunction

排除标准

  • cases reported in the World Health Organization (WHO) database of individual safety case reports (vigibase) related to adult patients

结局指标

主要结局

cancer therapy-related cardiac dysfunction associated with anticancer drugs

时间窗: from inception to the April 31, 2024

identification and description of cases of cancer therapy-related cardiac dysfunction associated with anticancer drugs in the World Health Organization (WHO) database of individual safety case reports (vigibase)

次要结局

  • Association between cancer therapy-related cardiac dysfunction and anticancer drug exposure in the World Health Organization (WHO) database of individual safety case reports (vigibase)(from inception to the April 31, 2024)
  • Description of the malignancies for which the incriminated drugs have been prescribed(from inception to the April 31, 2024)

研究者

申办方类型
Other
责任方
Sponsor

相似试验